December 2016
-
Freeman Technology will offer the new Graphical User Interface (GUI) for its FT4 powder rheometer instrument with all new instruments, and it will be available as a free upgrade for current owners. The FT4 provides… Read more . . .
-
The COPD Foundation has announced that COPD: Journal of Chronic Obstructive Pulmonary Disease will be its official journal. According to John W Walsh, President of the COPD Foundation, “COPD: Journal of Chronic Obstructive Pulmonary Disease,… Read more . . .
-
Biopharmaceutical company Insmed Incorporated has announced that its shareholders have approved a one-for-ten reverse stock split and the conversion of its Series B preferred stock into common stock. Insmed acquired Transave and its Arikace inhaled… Read more . . .
-
Submit poster and paper abstracts by May 27, 2011 to info@apsgb.org. See abstract guidelines (link opens Word document). Five £100 prizes will be awarded. Read more . . .
-
Submit call for papers form to hexagon@hexagon.dk or fax to +45 33 13 38 59. Read more . . .
-
Anyone interested in presenting should contact andrea.jandrea.james@management-forum.co.uk Read more . . .
-
Mangrove Partners, which holds approximately %5.7 of the outstanding shares of CPEX Pharmaceuticals, has announced that it will oppose the merger of CPEX with FCB, a wholly-owned subsidiary of Footstar Corporation. The merger was announced… Read more . . .
-
Savara Pharmaceuticals is seeking a high energy individual to fill a laboratory-based role in its formulation and analytical development laboratories. The successful candidate should be comfortable working in a start-up company and have experience supporting… Read more . . .
-
3M Drug Delivery Systems Division partners with pharmaceutical and biotech companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with regulatory… Read more . . .
-
We are seeking a highly motivated, experienced scientist to join the Pharmaceutical Development group at our early-stage pharmaceutical company to provide technical leadership and hands-on performance. The ideal candidate will have expertise in dry powder… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland